Pricing Log in Create free account

CASI Pharmaceuticals Inc. (CASIF) vs Cellectar Biosciences, Inc. (CLRB)

CASI Pharmaceuticals Inc. and Cellectar Biosciences, Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. is the larger, with a market value of $12.4M against $10.9M — 1.1× the size. Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cellectar Biosciences, Inc. leads on 7 and CASI Pharmaceuticals Inc. on 5.

Valuation

Metric CASIF CLRB Biotechnology median
P/E n/m n/m 10.26
P/S 0.09 n/m 9.18
P/B n/m 0.48 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.83 0.65
EV/Sales 1.79 n/m 8.98
Earnings yield (2,701.50%) (395.97%) (34.89%)
Free cash flow yield (3,801.00%) (137.75%) (24.52%)

Profitability

Metric CASIF CLRB Biotechnology median
Gross margin 48.65% 0.00% 65.16%
Operating margin (206.87%) 0.00% 0.00%
Net margin (232.03%) 0.00% 0.00%
Free cash flow margin (340.20%) 0.00% 0.00%
Return on equity 0.00% (125.99%) (50.12%)
Return on assets 0.00% (88.70%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CASIF CLRB Biotechnology median
Revenue growth (TTM) (27.42%) — 6.26%
EPS growth (last fiscal year) (1.17%) 80.07% 29.88%
Revenue growth, 5-year CAGR 6.47% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CASIF CLRB Biotechnology median
Debt to equity (0.34) 0.00 0.00
Current ratio 0.15 6.66 4.89
Net debt to EBITDA (0.43) 0.58 1.01

Dividend

Metric CASIF CLRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CASIF CLRB Biotechnology median
Market cap 12.39m 10.87m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack